US COVID-19 survivor gets whopping USD 1.1 million hospital bill; man was admitted for 62 days at medical facility in Washington
Michael Flor battled with coronavirus for 62 days at Swedish Issaquah, making him the longest coronavirus patient at the hospital.
Health ministry allows use of HCQ in early stages of COVID-19, Remdesivir in moderate patients as infections climb over 3.2 lakh
The government came out with a revised treatment protocol to deal with COVID-19, allowing use of antiviral drug Remdesivir in moderate cases and hydroxychloroquine in patients during the early course of the disease
Rajasthan seals its borders for a week as COVID-19 cases surge; state reports 123 new patients, total infections reach 11,368
The Rajasthan government sealed all state borders on Wednesday in view of a surge in COVID-19 cases. All movement to and from the state will be regulated. No person can enter Rajasthan without a 'No Objection Certificate' (NOC) from the state or leave without a pass, Director General Of Police, Law and Order, ML Lather said in an order.
Widespread use of face masks combined with lockdowns likely to prevent further waves of coronavirus pandemic, finds UK study
Population-wide face mask use could push COVID-19 transmission down to controllable levels for national epidemics and could prevent further waves of the pandemic disease when combined with lockdowns, according to a UK study
UK halts hydroxychloroquine trial after experts find no reduction in risk of death among coronavirus patients
British scientists halted a major drug trial after it found that the anti-malarial hydroxychloroquine was 'useless' at treating COVID-19 patients
Coronavirus epidemic not growing exponentially in India and South Asia, but risk of explosion looms, says WHO
The number of COVID-19 cases in India has been doubling every three weeks but the epidemic is not growing exponentially in the country and South Asia region, the WHO said
COVID-19 Treatment: Bemcentinib, Heparin and 3 other drugs to be tested by UK in their ACCORD programme
About 30 different hospitals in the UK are set to try five different drugs for COVID-19 treatment in phase II trials, as per a report by the Guardian.
India has allowed adults and children who have been hospitalised with severe COVID-19 symptoms to be treated with Remdesivir
The administration of this drug will be given to patients who show signs of a sever COVID-19 infection for a period of five days as well.
Lockdown is unlikely to yield any further dividend in India's fight against COVID-19, says virologist Shahid Jameel
"Building trust is most important so that people follow rules. A public health problem cannot be dealt with as a law-and-order problem," says virologist.
Coronavirus Outbreak: WHO pauses trial of hydroxychloroquine over safety concerns, clinical tests of other potential treatments to continue
The World Health Organization has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns
Remdesivir preliminary results from NIAID trial published; suggest improvement in recovery time from COVID-19
As per the study, the mortality rate by day 14 was 7.1% in the remdesivir group as compared to 11.9% in the placebo group.
Coronavirus in northeast China is mutating and people are taking longer to recover from the infection
Patients in the northeast also rarely exhibited fever and tended to suffer damage to the lungs rather than across multiple organs.
However, this could be signs of other respiratory infections hence experts say fever and persistent cough should be important symptoms to look out for.
Bangladesh medical team says Ivermectin with antibiotic Doxycycline works to treat COVID-19 patients
This drug combination was tried on 60 patients and they were tested negative in four days with 50 percent reduction of symptoms in three days.
Scientists in the US have started a clinical trial to check how azithromycin works in combination with the pneumonia drug atovaquone.
CDC issues guidelines to detect life threatening syndrome in children that could be linked to COVID-19
The syndrome is officially called “Pediatric Multi-System Inflammatory Syndrome Potentially Associated with COVID-19."
Gilead in talks to supply Remdesivir to Europe, Asia and other developing countries to treat Coronavirus
Gilead was authorised to use the drug as a treatment against COVID-19 after data showed remdesivir helped patients.
Favipiravir is a broad-spectrum antiviral drug that was originally made to treat the flu in Japan.
Report of the probe comes on the heels of the international community asking China for more transparency on how the virus originated.